Metastasis and cancer dormancy

Close metadata

Recommended articles:

Successful surgical treatment of a patient with pancreatic cancer metastases in the liver after prior pancreatoduodenal resection. P.A. Herzen Journal of Oncology. 2024;(2):54-59

Metastatic lesion of lymph nodes in papillary thyroid cancer on the background of autoimmune thyroiditis. P.A. Herzen Journal of Oncology. 2024;(3):27-33

Investigation of the oncological safety of a heterogeneous collagen-containing composition in an experimental model of breast cancer. P.A. Herzen Journal of Oncology. 2024;(6):50-56

Predicting the course of urgent abdominal diseases based on intensity of catabolic phenomena. Pirogov Russian Journal of Surgery. 2024;(4):44-48

Airway management in obese patients: a review. Russian Journal of Anesthesiology and Reanimatology. 2024;(3):67-73

Comparative analysis of combined treatment methods for patients with single brain lesions. Burdenko's Journal of Neurosurgery. 2024;(4):13-21

Melanoma metastasis to the brachial plexus and median nerve. A rare clinical case. Burdenko's Journal of Neurosurgery. 2024;(5):93-101

The role of biomarkers of endothelial dysfunction in predicting the progression of mild cognitive impairment in patients with cardiovascular risk factors. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):88-95

Diaphragm dysfunction as a prognostic criterion of external respiratory impairment and necessary extracorporeal membrane oxygenation in patients with chronic heart failure. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):38-45

Comparison of models for prediction of spontaneous preterm birth. Medical Technologies. Assessment and Choice. 2024;(4):10-19

The paper briefly considers difficulties creating the general conception of metastasis formation, basic metastatic stages, the characteristics of metastatic cancer cells, the types of cancer dormancy, as well as complexities and uncertainties in predicting the occurrence and development of metastases.

Keywords:

metastasis

cancer dormancy

prediction

Authors:

Kharchenko E.P.

Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia

ORCID: 0000-0001-6562-324X

Solov'ev I.A.

Kafedra voenno-morskoĭ i gospital'noĭ khirurgii Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

List of references:

Aparicio S, Hidalgo M, KungA L. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15(5):311-316. doi: 10.1038/nrc3944.
Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell. 2013;155(4):750-764. doi: 10.1016/j.cell.2013.10.029.
Oskarsson T, Batlle E, Massagué J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14(3):306-321. doi: 10.1016/j.stem.2014.02.002.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. doi: 10.1016/j.cell.2011.02.013.
Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438-1449. doi: 10.1038/nm.3336.
Kharchenko E. Some immunological aspects of carcinogenesis. Onkologiya. Zhurnal im. P.A. Gertsena. 2013;2(5):70-74. (In Russ.)
Chmielecki J, Meyerson M. DNA sequencing of cancer: what have we learned? Annu Rev Med. 2014;65:63-79. doi: 10.1146/annurev-med-060712-200152.
Pantel K, Denève E, Nocca D, Coffy A, Vendrell JP, Maudelonde T et al. Circulating epithelial cells in patients wi th benign colon diseases. Clin Chem. 2012;58(5):936-940. doi: 10.1373/clinchem.2011.175570.
Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science. 2008;321(5897):1841-1844. doi: 10.1126/science.1161621.
Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13(1):58-68. doi: 10.1016/j.ccr.2007.12.003.
Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013; 23(5):573-581. doi: 10.1016/j.ccr.2013.04.017.
Cowley AW Jr, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension. 2012;59(5):899-905. doi: 10.1161/HYPERTENSIONAHA.111.190116.
Wang X, Prince BP, Söber S, Laan M, Snieder H. Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension. Curr Hypertens Rep. 2011;13(6):442-451. doi: 10.1007/s11906-011-0230-y.
van Empel VPM, De Windt LJ, Martins PA. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens. Rep. 2012;14(6):498-509. doi: 10.1007/s11906-012-0310-7.
Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344-352. doi: 10.1038/nature12986.
Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell. 2013;24(4):410-421. doi: 10.1016/j.ccr.2013.09.007.
Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274-284. doi: 10.1038/nrc2622.
Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19(11):1450-1464. doi: 10.1038/nm.3391.
Demicheli R, Retsky MW, Hrushesky WJ, Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol. 2007;4(12):699-710.
Kharchenko E. Carcinogenesis: the immune system and immunotherapy. Immunologiya. 2011;32(1):50-56. (In Russ.).
Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611-622. doi: 10.1038/nrc3793.
Aguirre-Ghiso JA. Models, mechanisms and clinical evidence forcancer dormancy. Nat Rev Cancer. 2007;7(11):834-846.
Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS One. 2012;7(4):e35569. doi: 10.1371/journal.pone.0035569.
Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1-14.
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715-727.
Wang SH, Lin SY. Tumor dormancy: potential therapeutic target intumor recurrence and metastasis prevention. Exp Hematol Oncol. 2013;2(1):29-36. doi: 10.1186/2162-3619-2-29.
Kharchenko EP. Immune privilege: the pathological aspect. Immunologiya. 2009;30(4):249-255. (In Russ.)
Thom R. Catastrophe theory: its present state and future perspectives. Warwick: Springer Verlag; 1974.
Prigogine I, Stengers I. Order out of chaos. Man's new dialogue with nature. Heinemann, London; 1984.
Rini B. Future approaches in immunotherapy. Semin Oncol. 2014;41(Suppl.5):S30-S40. doi: 10.1053/j.seminoncol.2014.09.005.
Weber JS. Current perspectives on immunotherapy. Semin Oncol. 2014;41(Suppl.5):S14-S29. doi: 10.1053/j.seminoncol.2014.09.003.

Close metadata